Format

Send to:

Choose Destination
See comment in PubMed Commons below
J Control Release. 2012 Jul 20;161(2):416-21. doi: 10.1016/j.jconrel.2012.03.012. Epub 2012 Mar 20.

Public-private partnerships in translational medicine: concepts and practical examples.

Author information

  • 1Center for Translational Molecular Medicine, High Tech Campus 84 5656 AG Eindhoven. peter.luijten@ctmm.nl

Abstract

The way forward in multidisciplinary research according to former NIH's director Elias Zerhouni is to engage in predictive, personalized, preemptive and participatory medicine. For the creation of the optimal innovation climate that would allow for such a strategy, public-private partnerships have been widely proposed as an important instrument. Public-private partnerships have become an important instrument to expedite translational research in medicine. The Netherlands have initiated three large public-private partnerships in the life sciences and health area to facilitate the translation of valuable basic scientific concepts to new products and services in medicine. The focus of these partnerships has been on drug development, improved diagnosis and regenerative medicine. The Dutch model of public-private partnership forms the blueprint of a much larger European initiative called EATRIS. This paper will provide practical examples of public-private partnerships initiated to expedite the translation of new technology for drug development towards the clinic. Three specific technologies are in focus: companion diagnostics using nuclear medicine, the use of ultra high field MRI to generate sensitive surrogate endpoints based on endogenous contrast, and MRI guidance for High Intensity Focused Ultrasound mediated drug delivery.

Copyright © 2012 Elsevier B.V. All rights reserved.

PMID:
22465390
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science
    Loading ...
    Write to the Help Desk